The News Feed


AI Sheds Light on DME Treatment Efficacy

Aflibercept and ranibizumab reduced more intraretinal fluid than bevacizumab.
August 10, 2020

AI Retinopathy Screening On Par with Human Grading

The algorithm had 100% sensitivity for diagnosing proliferative disease.
August 7, 2020

New Biomarkers Spur Re-evaluation of Neuritis Incidence

They account for 9% of cases and are associated with recurrent attacks.
August 6, 2020

Retinal Distinctions Apparent in Black DR Patients

Race-specific biomarkers could help reduce the risk of vision loss in this population.
August 6, 2020

OCT-A Gets High Marks for Monitoring Anti-VEGF Success

CNV lesions had an immediate reaction on day one that lasted two weeks.
August 5, 2020

Angioid Streaks Associated With PXE Complications

This clinical sign is linked with a higher prevalence of CNV and more severe macular atrophy.
August 3, 2020

Watch for Post-injection IOP Rise in PXF Patients

Those with AMD and pseudoexfoliation showed elevated pressure after long-term bevacizumab treatment.
July 29, 2020

Long-term Vitrectomy Outcomes: a Mixed Bag

Some patients may need re-treatment after 10 years, and more than half need the surgery in the fellow eye.
July 23, 2020

RNFL Thins with Microvasculature Dropout

This finding was prevalent in eyes with primary open-angle glaucoma and disc hemorrhage.
July 21, 2020

Inflammation Key Predictor of RD

Research demonstrates that early and vigorous control of inflammation can prevent sequelae.
July 21, 2020